Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
PH vs EMR vs ETN vs HON vs ROK
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Industrial - Machinery
Conglomerates
Industrial - Machinery
PH vs EMR vs ETN vs HON vs ROK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery | Conglomerates | Industrial - Machinery |
| Market Cap | $111.85B | $79.02B | $155.02B | $136.91B | $50.37B |
| Revenue (TTM) | $20.99B | $18.32B | $28.52B | $36.76B | $8.80B |
| Net Income (TTM) | $3.48B | $2.44B | $3.99B | $4.10B | $1.09B |
| Gross Margin | 37.2% | 52.7% | 36.9% | 36.9% | 52.5% |
| Operating Margin | 20.9% | 19.8% | 18.1% | 14.9% | 19.1% |
| Forward P/E | 28.6x | 21.7x | 30.0x | 20.5x | 36.9x |
| Total Debt | $9.64B | $13.76B | $11.17B | $34.58B | $3.65B |
| Cash & Equiv. | $467M | $1.54B | $622M | $12.49B | $468M |
PH vs EMR vs ETN vs HON vs ROK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Parker-Hannifin Cor… (PH) | 100 | 492.4 | +392.4% |
| Emerson Electric Co. (EMR) | 100 | 231.2 | +131.2% |
| Eaton Corporation p… (ETN) | 100 | 470.2 | +370.2% |
| Honeywell Internati… (HON) | 100 | 148.1 | +48.1% |
| Rockwell Automation… (ROK) | 100 | 207.4 | +107.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PH vs EMR vs ETN vs HON vs ROK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PH is the #2 pick in this set and the best alternative if long-term compounding and valuation efficiency is your priority.
- 7.4% 10Y total return vs ETN's 6.1%
- PEG 1.20 vs HON's 11.18
- 16.6% margin vs HON's 11.2%
- 11.5% ROA vs HON's 5.3%, ROIC 13.4% vs 12.6%
Among these 5 stocks, EMR doesn't own a clear edge in any measured category.
ETN ranks third and is worth considering specifically for growth exposure.
- Rev growth 10.3%, EPS growth 10.1%, 3Y rev CAGR 9.8%
- 10.3% revenue growth vs PH's -0.4%
HON carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 15 yrs, beta 0.74, yield 2.1%
- Lower volatility, beta 0.74, current ratio 1.32x
- Beta 0.74, yield 2.1%, current ratio 1.32x
- Lower P/E (20.5x vs 36.9x)
ROK is the clearest fit if your priority is momentum.
- +60.2% vs HON's +2.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.3% revenue growth vs PH's -0.4% | |
| Value | Lower P/E (20.5x vs 36.9x) | |
| Quality / Margins | 16.6% margin vs HON's 11.2% | |
| Stability / Safety | Beta 0.74 vs EMR's 1.52 | |
| Dividends | 2.1% yield, 15-year raise streak, vs EMR's 1.5% | |
| Momentum (1Y) | +60.2% vs HON's +2.8% | |
| Efficiency (ROA) | 11.5% ROA vs HON's 5.3%, ROIC 13.4% vs 12.6% |
PH vs EMR vs ETN vs HON vs ROK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PH vs EMR vs ETN vs HON vs ROK — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
PH leads in 2 of 6 categories
HON leads 1 • ROK leads 1 • EMR leads 0 • ETN leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
PH leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HON is the larger business by revenue, generating $36.8B annually — 4.2x ROK's $8.8B. PH is the more profitable business, keeping 16.6% of every revenue dollar as net income compared to HON's 11.2%. On growth, ETN holds the edge at +16.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $21.0B | $18.3B | $28.5B | $36.8B | $8.8B |
| EBITDAEarnings before interest/tax | $5.1B | $4.7B | $5.9B | $6.5B | $1.9B |
| Net IncomeAfter-tax profit | $3.5B | $2.4B | $4.0B | $4.1B | $1.1B |
| Free Cash FlowCash after capex | $3.7B | $3.1B | $4.7B | $4.2B | $1.3B |
| Gross MarginGross profit ÷ Revenue | +37.2% | +52.7% | +36.9% | +36.9% | +52.5% |
| Operating MarginEBIT ÷ Revenue | +20.9% | +19.8% | +18.1% | +14.9% | +19.1% |
| Net MarginNet income ÷ Revenue | +16.6% | +13.3% | +14.0% | +11.2% | +12.4% |
| FCF MarginFCF ÷ Revenue | +17.5% | +17.0% | +16.5% | +11.4% | +15.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +10.6% | +2.9% | +16.8% | -6.9% | +11.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -4.2% | +28.2% | -9.4% | -41.9% | +39.6% |
Valuation Metrics
HON leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 29.4x trailing earnings, HON trades at a 50% valuation discount to ROK's 58.5x P/E. Adjusting for growth (PEG ratio), PH offers better value at 1.37x vs HON's 15.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $111.8B | $79.0B | $155.0B | $136.9B | $50.4B |
| Enterprise ValueMkt cap + debt − cash | $121.0B | $91.2B | $165.6B | $159.0B | $53.6B |
| Trailing P/EPrice ÷ TTM EPS | 32.68x | 34.92x | 38.17x | 29.36x | 58.45x |
| Forward P/EPrice ÷ next-FY EPS est. | 28.58x | 21.71x | 30.00x | 20.52x | 36.93x |
| PEG RatioP/E ÷ EPS growth rate | 1.37x | 7.73x | 1.55x | 15.99x | — |
| EV / EBITDAEnterprise value multiple | 24.36x | 18.07x | 27.69x | 19.99x | 30.64x |
| Price / SalesMarket cap ÷ Revenue | 5.63x | 4.39x | 5.65x | 3.66x | 6.04x |
| Price / BookPrice ÷ Book value/share | 8.43x | 3.94x | 7.99x | 9.00x | 13.66x |
| Price / FCFMarket cap ÷ FCF | 33.48x | 29.63x | 34.67x | 25.39x | 37.09x |
Profitability & Efficiency
ROK leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
ROK delivers a 29.6% return on equity — every $100 of shareholder capital generates $30 in annual profit, vs $12 for EMR. ETN carries lower financial leverage with a 0.57x debt-to-equity ratio, signaling a more conservative balance sheet compared to HON's 2.24x. On the Piotroski fundamental quality scale (0–9), PH scores 8/9 vs HON's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +24.3% | +12.1% | +20.8% | +23.1% | +29.6% |
| ROA (TTM)Return on assets | +11.5% | +5.8% | +9.0% | +5.3% | +9.7% |
| ROICReturn on invested capital | +13.4% | +8.2% | +13.6% | +12.6% | +15.1% |
| ROCEReturn on capital employed | +17.8% | +10.0% | +16.8% | +12.6% | +18.5% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 7 | 6 | 6 | 8 |
| Debt / EquityFinancial leverage | 0.70x | 0.68x | 0.57x | 2.24x | 0.98x |
| Net DebtTotal debt minus cash | $9.2B | $12.2B | $10.5B | $22.1B | $3.2B |
| Cash & Equiv.Liquid assets | $467M | $1.5B | $622M | $12.5B | $468M |
| Total DebtShort + long-term debt | $9.6B | $13.8B | $11.2B | $34.6B | $3.6B |
| Interest CoverageEBIT ÷ Interest expense | 11.39x | 6.46x | 16.38x | 3.92x | 9.06x |
Total Returns (Dividends Reinvested)
PH leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PH five years ago would be worth $28,635 today (with dividends reinvested), compared to $10,326 for HON. Over the past 12 months, ROK leads with a +60.2% total return vs HON's +2.8%. The 3-year compound annual growth rate (CAGR) favors PH at 39.3% vs HON's 5.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -0.7% | +4.3% | +22.3% | +10.9% | +12.8% |
| 1-Year ReturnPast 12 months | +43.4% | +30.4% | +33.2% | +2.8% | +60.2% |
| 3-Year ReturnCumulative with dividends | +170.5% | +75.9% | +141.3% | +16.2% | +65.0% |
| 5-Year ReturnCumulative with dividends | +186.4% | +59.5% | +182.8% | +3.3% | +74.6% |
| 10-Year ReturnCumulative with dividends | +737.4% | +206.6% | +608.7% | +135.1% | +341.0% |
| CAGR (3Y)Annualised 3-year return | +39.3% | +20.7% | +34.1% | +5.1% | +18.2% |
Risk & Volatility
Evenly matched — HON and ROK each lead in 1 of 2 comparable metrics.
Risk & Volatility
HON is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ROK currently trades 96.7% from its 52-week high vs EMR's 85.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.00x | 1.52x | 1.42x | 0.74x | 1.33x |
| 52-Week HighHighest price in past year | $1034.96 | $165.15 | $435.43 | $248.18 | $463.49 |
| 52-Week LowLowest price in past year | $616.56 | $108.37 | $296.93 | $186.76 | $277.66 |
| % of 52W HighCurrent price vs 52-week peak | +85.6% | +85.4% | +91.7% | +87.1% | +96.7% |
| RSI (14)Momentum oscillator 0–100 | 42.6 | 61.3 | 59.8 | 45.1 | 74.9 |
| Avg Volume (50D)Average daily shares traded | 710K | 2.8M | 2.5M | 3.7M | 831K |
Analyst Outlook
Evenly matched — EMR and HON each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PH as "Buy", EMR as "Buy", ETN as "Buy", HON as "Buy", ROK as "Hold". Consensus price targets imply 17.6% upside for PH (target: $1042) vs -4.9% for ETN (target: $380). For income investors, HON offers the higher dividend yield at 2.14% vs PH's 0.75%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $1042.08 | $161.92 | $379.78 | $243.83 | $436.56 |
| # AnalystsCovering analysts | 38 | 41 | 39 | 28 | 39 |
| Dividend YieldAnnual dividend ÷ price | +0.7% | +1.5% | +1.0% | +2.1% | +1.2% |
| Dividend StreakConsecutive years of raises | 33 | 37 | 24 | 15 | 20 |
| Dividend / ShareAnnual DPS | $6.61 | $2.10 | $4.17 | $4.63 | $5.23 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.6% | +1.6% | +1.2% | +2.8% | +0.8% |
PH leads in 2 of 6 categories (Income & Cash Flow, Total Returns). HON leads in 1 (Valuation Metrics). 2 tied.
PH vs EMR vs ETN vs HON vs ROK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PH or EMR or ETN or HON or ROK a better buy right now?
For growth investors, Eaton Corporation plc (ETN) is the stronger pick with 10.
3% revenue growth year-over-year, versus -0. 4% for Parker-Hannifin Corporation (PH). Honeywell International Inc. (HON) offers the better valuation at 29. 4x trailing P/E (20. 5x forward), making it the more compelling value choice. Analysts rate Parker-Hannifin Corporation (PH) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PH or EMR or ETN or HON or ROK?
On trailing P/E, Honeywell International Inc.
(HON) is the cheapest at 29. 4x versus Rockwell Automation, Inc. at 58. 5x. On forward P/E, Honeywell International Inc. is actually cheaper at 20. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Parker-Hannifin Corporation wins at 1. 20x versus Honeywell International Inc. 's 11. 18x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — PH or EMR or ETN or HON or ROK?
Over the past 5 years, Parker-Hannifin Corporation (PH) delivered a total return of +186.
4%, compared to +3. 3% for Honeywell International Inc. (HON). Over 10 years, the gap is even starker: PH returned +737. 4% versus HON's +135. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PH or EMR or ETN or HON or ROK?
By beta (market sensitivity over 5 years), Honeywell International Inc.
(HON) is the lower-risk stock at 0. 74β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 105% more volatile than HON relative to the S&P 500. On balance sheet safety, Eaton Corporation plc (ETN) carries a lower debt/equity ratio of 57% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PH or EMR or ETN or HON or ROK?
By revenue growth (latest reported year), Eaton Corporation plc (ETN) is pulling ahead at 10.
3% versus -0. 4% for Parker-Hannifin Corporation (PH). On earnings-per-share growth, the picture is similar: Parker-Hannifin Corporation grew EPS 24. 2% year-over-year, compared to -15. 5% for Honeywell International Inc.. Over a 3-year CAGR, ETN leads at 9. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PH or EMR or ETN or HON or ROK?
Parker-Hannifin Corporation (PH) is the more profitable company, earning 17.
8% net margin versus 10. 4% for Rockwell Automation, Inc. — meaning it keeps 17. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PH leads at 20. 5% versus 17. 1% for ROK. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PH or EMR or ETN or HON or ROK more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Parker-Hannifin Corporation (PH) is the more undervalued stock at a PEG of 1. 20x versus Honeywell International Inc. 's 11. 18x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Honeywell International Inc. (HON) trades at 20. 5x forward P/E versus 36. 9x for Rockwell Automation, Inc. — 16. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PH: 17. 6% to $1042. 08.
08Which pays a better dividend — PH or EMR or ETN or HON or ROK?
All stocks in this comparison pay dividends.
Honeywell International Inc. (HON) offers the highest yield at 2. 1%, versus 0. 7% for Parker-Hannifin Corporation (PH).
09Is PH or EMR or ETN or HON or ROK better for a retirement portfolio?
For long-horizon retirement investors, Parker-Hannifin Corporation (PH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
00), 0. 7% yield, +737. 4% 10Y return). Emerson Electric Co. (EMR) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PH: +737. 4%, EMR: +206. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PH and EMR and ETN and HON and ROK?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.